News

Home News

05

May2022

CADTH Update: Advice on Real-World Evidence (RWE) by Scientific Advice Program

/ CADTH, News, What's New
On May 3, 2022, CADTH announced the mandate expansion of the Scientific Advice Program to include advice on ... Read More

25

Apr2022

The PMPRB to consult on a different set of guidelines

/ PMPRB, What's New
On April 14, 2022, Health Canada announced that the government will:  Proceed only with the proposed amendments to ... Read More

11

Apr2022

CADTH: New Clinical Evidence Template Requirement for October 2022 Submissions

/ CADTH, News
The Canadian Agency for Drugs and Technologies in Health (CADTH) has published Issue 28 of its Pharmaceutical Reviews ... Read More

04

Apr2022

PMPRB 2020 Annual Report Shows Almost 30% Decrease in New Patented Medicines Reported Since 2018

/ PMPRB, What's New
On March 31, 2022, PMPRB published its 2020 Annual Report on its website. Key statistics reinforce concerns about ... Read More

25

Mar2022

Supreme Court Dismisses Attorney General’s Application for Leave to Appeal FCA decision in PMPRB Alexion Soliris Matter

/ News, PMPRB, What's New
On September 29, 2021, the Attorney General of Canada applied for leave to appeal to the Supreme Court ... Read More

22

Feb2022

Quebec Court Strikes 2 of 3 PMPRB Changes

/ PMPRB, What's New
On February 18, 2022, the Quebec Court of Appeal ruled that two of the three major proposed changes ... Read More

14

Feb2022

Reminder: Form 3 filing is due to the PMPRB On March 1, 2022

/ News, PMPRB, What's New
This is a reminder to patentees of their filing requirements respecting revenues and development expenditures. These filing requirements ... Read More

31

Jan2022

Updates to the Ontario Guidelines for Drug Submission and Evaluation

/ Ontario, What's New
The Ontario Ministry of Health has recently updated the Ontario Guidelines for Drug Submission and Evaluation (Guidelines). In ... Read More